Home/Filings/4/0001562180-25-002697
4//SEC Filing

Vaddi Krishna 4

Accession 0001562180-25-002697

CIK 0001678660other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 5:03 PM ET

Size

11.9 KB

Accession

0001562180-25-002697

Insider Transaction Report

Form 4
Period: 2025-03-20
Vaddi Krishna
DirectorCEO
Transactions
  • Purchase

    Common Stock

    2025-03-20$0.73/sh+5,416$3,9501,309,296 total
  • Purchase

    Common Stock

    2025-03-21$0.73/sh+15,000$10,9591,324,296 total
Holdings
  • Common Stock

    (indirect: See footnote)
    142,553
  • Common Stock

    (indirect: By Trust)
    551,776
  • Common Stock

    (indirect: By Trust)
    551,774
  • Common Stock

    (indirect: By Trust)
    423,655
Footnotes (6)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7294 to $0.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.73 to $0.731, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  • [F3]The Reporting Person is a beneficiary of the Dolphin City Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
  • [F4]The Reporting Person is the investment advisor of the Brocade Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
  • [F5]The Reporting Person is the investment advisor of the Blue Sky Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
  • [F6]The Reporting Person is the manager of Sidus Ventures LLC. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Issuer

Prelude Therapeutics Inc

CIK 0001678660

Entity typeother

Related Parties

1
  • filerCIK 0001824633

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 5:03 PM ET
Size
11.9 KB